PMID- 21870300 OWN - NLM STAT- MEDLINE DCOM- 20111228 LR - 20180802 IS - 1424-3997 (Electronic) IS - 0036-7672 (Linking) VI - 141 DP - 2011 TI - No association between herpes simplex virus 1 and cardiac myxoma. PG - w13223 LID - 10.4414/smw.2011.13223 [doi] AB - PRINCIPLES: Cardiac myxoma is the most commonly diagnosed cardiac tumour. Infection of herpes simplex virus 1 (HSV1) has been postulated to be a factor for this pathologic entity. The aim of the current study was to evaluate the association between HSV 1 and myxoma occurrence. METHODS: Between 1965 and 2005, 70 patients (36 female, mean age: 52.6 years) underwent a resection of myxoma. Selected variables such as hospital mortality and morbidity were studied. A follow-up (FU; mean FU time: 138 +/- 83 months) was obtained (76% complete). Immunohistological studies with monoclonal antibodies against HSV type 1 were performed on tumour biopsies of 40 patients. RESULTS: The mean age was 53 +/- 16 years (range 23 to 84 years, 51% female). Of the investigated population, 31 (44%) were in New York Heart Association (NYHA) class III-IV. Mitral valve stenosis was identified in 14 patients (20%), and in 25 (36%) patients mitral valve was insufficient. During hospitalisation 3 patients suffered from a transient neurological disorder, and in addition to myxoma resection 18 (25.7%) patients had to undergo an additional intervention. The overall survival rate was 91% at 40 years. There was no early postoperative mortality in follow-up, although 4 patients died and 2 patients had been re-operated on for recurrent myxomas after 2 and 9 years. Immunohistology revealed no positive signals for HSV-1 antigens among the 40 analysed cases. CONCLUSION: Complete surgical resection, septum included, was the treatment of choice and mandatory to prevent relapse. Peri-operative morbidity and mortality over 40 years remained low, and no association between HSV infection and occurrence of cardiac myxoma was found. FAU - Schurr, Ulrich P AU - Schurr UP AD - Department of Cardiac Surgery, Triemli Hospital, Zurich, Switzerland. Ulrich.Schurr@triemli.stzh.ch FAU - Berdajs, Denis A AU - Berdajs DA FAU - Bode, Beate AU - Bode B FAU - Dzemali, Omer AU - Dzemali O FAU - Emmert, Maximilian Y AU - Emmert MY FAU - Genoni, Michele AU - Genoni M LA - eng PT - Journal Article DEP - 20110826 PL - Switzerland TA - Swiss Med Wkly JT - Swiss medical weekly JID - 100970884 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Female MH - Follow-Up Studies MH - Heart Neoplasms/pathology/surgery/*virology MH - Herpesviridae Infections/*complications MH - *Herpesvirus 1, Human MH - Humans MH - Immunohistochemistry MH - Male MH - Middle Aged MH - Myxoma/pathology/surgery/*virology MH - *Neoplasm Recurrence, Local MH - Young Adult EDAT- 2011/08/27 06:00 MHDA- 2011/12/29 06:00 CRDT- 2011/08/27 06:00 PHST- 2011/08/27 06:00 [entrez] PHST- 2011/08/27 06:00 [pubmed] PHST- 2011/12/29 06:00 [medline] AID - smw-13223 [pii] AID - 10.4414/smw.2011.13223 [doi] PST - epublish SO - Swiss Med Wkly. 2011 Aug 26;141:w13223. doi: 10.4414/smw.2011.13223. eCollection 2011.